Global Nanotechnology Drug Delivery Systems Market by Technologies, Applications, Growth Trends and Forecast to 2021

Nanotechnology drug delivery systems involve the engineering of functional systems at the molecular scale, characterized by unique physical, optical and electronic features. Nanomedicine is a highly specific medical intervention for the prevention, diagnosis and treatment of diseases. Several anti-cancer drugs including paclitaxel, doxorubicin, 5-fluorouracil and dexamethasone have been successfully formulated using nanomaterials. Quantom dots, chitosan, Polylactic or glycolic acid (PLGA) and PLGA-based nanoparticles have also been used for in vitro RNAi delivery. The ability of nanotechnology to provide targeted drug delivery, improved solubility, extended half-life and reduce a drug’s immunogenicity has resulted in the potential to revolutionize the treatment of many diseases. Over the last two decades, significant progress has been made in the field of nanomedicine, resulting in a number of products, including therapeutics and imaging agents, enabling more effective and less toxic therapeutic and diagnostic interventions

Browse Nanotechnology Drug Delivery Systems Market by Technology Types (Nanocrystals, Nanoparticles, Dendrimers, Gold Nanoparticles, Fullerenes, Liposomes, Micelles, Nanotubes), and Applications (Anti-Infective, Anti-Inflammatory, Immunology, Cardiovascular, Physiology, Neurology, Oncology) and Forecast 2017-2021 at https://www.ihealthcareanalyst.com/report/nanotechnology-drug-delivery-systems-market/

The global nanotechnology drug delivery systems market segmentation is based on technology types (nanocrystals, nanoparticles, dendrimers, gold nanoparticles, fullerenes, liposomes, micelles, nanotubes), and its applications (anti-infective, anti-inflammatory, immunology, cardiovascular, physiology, neurology, oncology). The global nanotechnology drug delivery systems market report provides market size (Revenue USD Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021). The global nanotechnology drug delivery systems market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global nanotechnology drug delivery systems market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Major players operating in the global nanotechnology drug delivery systems market and included in this report are AbbVie, Amgen, Celgene Corporation, Elan Pharmaceuticals, Johnson & Johnson, Pfizer, Inc., Merck & Co., Novartis AG, and Teva Pharmaceuticals.

1. Technology
1.1. Nanocrystals
1.2. Nanoparticles
1.3. Dendrimers
1.4. Gold Nanoparticles
1.5. Fullerenes
1.6. Liposomes
1.7. Micelles
1.8. Nanotubes
1.9. Others

2. Application
2.1. Anti-infective
2.2. Anti-inflammatory/Immunology
2.3. Cardiovascular/Physiology
2.4. Neurology
2.5. Oncology
2.6. Others

3. Geography (Region, Country)
3.1. North America (U.S., Canada)
3.2. Latin America (Brazil, Mexico, Rest of LA)
3.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.4. Asia Pacific (Japan, China, India, Rest of APAC)
3.5. Rest of the World

4. Company Profiles
4.1. AbbVie, Inc.
4.2. Amgen Inc.
4.3. Celgene Corporation
4.4. Johnson & Johnson
4.5. Merck & Co., Inc.
4.6. Novartis International AG
4.7. Perrigo Company plc
4.8. Pfizer, Inc.
4.9. Teva Pharmaceutical Industries Ltd.

To request Table of Contents and Sample Pages of this report visit:
https://www.ihealthcareanalyst.com/report/nanotechnology-drug-delivery-systems-market/

iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare IT, healthcare services, medical devices, medical equipment, and pharmaceuticals.

In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.

Ana Aitawa
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareanalyst.com
https://www.ihealthcareanalyst.com

This release was published on openPR.